ATE145213T1 - Kardioaktive steroide - Google Patents

Kardioaktive steroide

Info

Publication number
ATE145213T1
ATE145213T1 AT92200375T AT92200375T ATE145213T1 AT E145213 T1 ATE145213 T1 AT E145213T1 AT 92200375 T AT92200375 T AT 92200375T AT 92200375 T AT92200375 T AT 92200375T AT E145213 T1 ATE145213 T1 AT E145213T1
Authority
AT
Austria
Prior art keywords
cardioactive
steroids
cardioactive steroids
chem
formula
Prior art date
Application number
AT92200375T
Other languages
English (en)
Inventor
Giorgio Bertolini
Cesare Casagrande
Stefania Montanari
Gabriele Norcini
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE145213T1 publication Critical patent/ATE145213T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92200375T 1991-02-14 1992-02-11 Kardioaktive steroide ATE145213T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910380A IT1250410B (it) 1991-02-14 1991-02-14 Composti steroidei attivi sul sistema cardiovascolare

Publications (1)

Publication Number Publication Date
ATE145213T1 true ATE145213T1 (de) 1996-11-15

Family

ID=11358571

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92200375T ATE145213T1 (de) 1991-02-14 1992-02-11 Kardioaktive steroide

Country Status (7)

Country Link
US (1) US5426179A (de)
EP (1) EP0499327B1 (de)
JP (1) JPH0565293A (de)
AT (1) ATE145213T1 (de)
DE (1) DE69215125T2 (de)
ES (1) ES2096014T3 (de)
IT (1) IT1250410B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4232681C2 (de) * 1992-09-29 1994-11-24 Sigma Tau Ind Farmaceuti 17-Phenyl- und 17-Furyl-14beta,5alpha-androstan- und androsten- Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
US5597806A (en) * 1995-05-09 1997-01-28 Merck & Co., Inc. Antifungal agents
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
EP3664470B1 (de) 2018-12-05 2021-02-17 Sonova AG Bereitstellung von feedback der lautstärke der eigenen stimme eines benutzers eines hörgeräts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968132A (en) * 1974-12-23 1976-07-06 Schering Corporation (17R)-Spiro-[androstane-17,1'-cyclobutan]-2'-ones, methods for their manufacture and intermediates useful therein
DE2546779A1 (de) * 1975-10-18 1977-04-28 Boehringer Mannheim Gmbh Neue 20.22-dihydro-cardenolid- glykoside
FR2451923A1 (fr) * 1979-03-22 1980-10-17 Roussel Uclaf Nouveaux derives steroides 7-alkyles, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
EP0499327B1 (de) 1996-11-13
EP0499327A1 (de) 1992-08-19
DE69215125T2 (de) 1997-06-12
IT1250410B (it) 1995-04-07
US5426179A (en) 1995-06-20
ITMI910380A1 (it) 1992-08-14
ES2096014T3 (es) 1997-03-01
JPH0565293A (ja) 1993-03-19
ITMI910380A0 (it) 1991-02-14
DE69215125D1 (de) 1996-12-19

Similar Documents

Publication Publication Date Title
NO881857L (no) Steroide 5-alfa-reduktase-inhibitorer.
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
EP1042352A4 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
FI941791A0 (fi) Pienisäröinen myötäkytkentävahvistin
FI930632A7 (fi) Kytkentä lähetinvahvistimen tehon säätämiseksi
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
DE69214777D1 (de) Monolithisch integrierter Mikrowellenverstärker mit hoher Verstärkung
EP0227450A3 (de) Substituierte 5,6-Dialkoxychinazolin-Derivate
DE69215125D1 (de) Kardioaktive Steroide
DE69319966D1 (de) Nichtlineare Verstärkungsregelung für PLL-Schaltungen
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
FI923965A7 (fi) Heterosyklisiä steroidiyhdisteitä
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
ITMI920076A1 (it) Composti steroidei 17-aril-sostituiti attivi sul sistema cardiovascolare
DE69302911D1 (de) 17-(Pyridazin-N-Oxyd)-substituierte Steroide mit cardiotonischer Wirksamkeit
DE69303063D1 (de) Gegentaktausgangsstufe für integrierten Verstärker
PL312966A1 (en) Derivatives of thiocarbamoil
DE69402846D1 (de) Funkzwischenverstärker
ATE124417T1 (de) 2,19-methylenoxy- und 2,19-methylenthiogebrückte steroide und ihre verwendung als inhibitoren von aromatase und 19-hydroxylase.
KR940027713U (ko) 출력레벨조정을 위한 광대역 증폭회로
KR950007476U (ko) 반전 증폭기 이득 조정 회로
NO891776L (no) Steroide 5-alfa-reduktase-inhibitorer.
NO891775D0 (no) Steroide 5-alfa-reduktase-inhibitorer.
GR1001405B (el) Ενώσεις 2-πιπεραζινόνης και η παραγωγή και η χρησιμοποίηση αυτών.
ITMI931728A1 (it) Composti eterociclici ad attivita' cardiovascolare

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties